urea has been researched along with pyrrolidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amphlett, EM; Andrews, DM; Bamborough, P; Carey, SJ; Johnson, MR; Jones, PS; Mills, G; Parry, NR; Skarzynski, T; Slater, MJ; Somers, DO; Stewart, AJ | 1 |
| Davis, JB; Fell, S; Gunthorpe, MJ; Jerman, JC; Rami, HK; Randall, AD; Sanderson, D; Sargent, B; Smart, D; Stemp, G; Stevens, AJ; Thompson, M | 1 |
| Ben-Hassine, M; Braun, A; Crespin, O; Dadji-Faïhun, R; Engel, C; Farjot, G; Güssregen, S; Leger, C; Maniani, K; Monseau, C; Mougenot, C; Mougenot, P; Namane, C; Nicolaï, E; Noah, L; Onofri, B; Pacquet, F; Pascal, C; Philippo, C; Ragot, JL; Van-Pham, T; Venier, O | 1 |
3 other study(ies) available for urea and pyrrolidine
| Article | Year |
|---|---|
Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 urea leads to potent intracellular inhibitors of hepatitis C virus NS3/4A protease.
Topics: Antiviral Agents; Crystallography, X-Ray; Hepacivirus; Inhibitory Concentration 50; Lactams; Molecular Conformation; Molecular Structure; Protease Inhibitors; Pyrrolidines; Urea; Viral Nonstructural Proteins; Virus Replication | 2003 |
Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development.
Topics: Administration, Oral; Animals; Capsaicin; Cell Line; Drug Design; Guinea Pigs; Humans; Molecular Structure; Pyrrolidines; Rats; Structure-Activity Relationship; TRPV Cation Channels; Urea | 2006 |
Pyrrolidine-pyrazole ureas as potent and selective inhibitors of 11β-hydroxysteroid-dehydrogenase type 1.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Administration, Oral; Animals; Binding Sites; Crystallography, X-Ray; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Mice; Pyrazoles; Pyrrolidines; Urea | 2011 |